MPH Health Care shares are from a German private equity firm. The company primarily invests in healthcare companies, particularly in generics and specialty pharmaceuticals. MPH is listed on the CDAX and is therefore part of the broader German stock market.
The business model is relatively easy to explain: MPH holds stakes in healthcare companies and profits from their performance. If the investments perform well or pay dividends, this impacts MPH's results.
TransparentShare had already issued a buy recommendation for the stock on March 27, 2024, at a price of €21. Since then, the stock has been a regular focus of their analysis.
The stock is currently in focus because it offers an attractive dividend yield of around 5.24 percent and, according to TransparentShare, is once again rated as a buy. At the same time, the share price is trading below previous highs, which is attracting interest from many investors.
News: What events were important in recent weeks?
In recent weeks, two main topics have been in the spotlight.
First: The discussion about the development of investments in the healthcare sector. Generic drug manufacturers in particular benefit from stable demand, as medications are needed regardless of the economic climate.
Secondly: The upcoming Annual General Meeting on July 9, 2026. This date is particularly relevant for dividend investors, as the distribution will be decided at this meeting.
Such dates are important for shareholders because they can have a direct impact on dividend payments and strategic direction.
Current price: What is the current share price?
The MPH Health Care share price is currently at €23.00 (as of February 24, 2026). The difference to the high is approximately 20 percent.
Over the past six months, the stock has performed well compared to the index. However, over a twelve-month period, it is still slightly underperforming the overall market.
For beginners, this means: The stock shows short-term strength but still has potential for growth over the course of the year. At the same time, companies holding investments are subject to greater fluctuations, as their performance depends on the value of their investments.
MPH Health Care: What aspects of the figures are of particular interest to investors?
Four points are central to the analysis of MPH Health Care stock:
- Revenue and profit: The profit margin is around 50 percent. This is considerable for an investment company, but depends heavily on the returns of the investments.
- Outlook: The crucial factor is how the investments develop and whether stable distributions remain possible.
- Evaluation: The current price-to-earnings ratio is around 7.27, which is at a moderate level.
- Market reaction: The share price reacted slightly negatively following the release of quarterly figures. Such movements are not unusual for smaller stocks.
Investors should understand that private equity firms operate differently than traditional industrial companies. Their value depends heavily on their portfolio. The strategic focus of their activities is on acquiring and developing companies and company shares, particularly in growth segments of the healthcare and pharmaceutical markets. This includes both insurance-funded ("primary" healthcare market) and privately funded ("secondary" healthcare market) segments.
Outlook: What could become important in the coming weeks?
The most important date at present is the Annual General Meeting on July 9, 2026. The dividend will be decided at this meeting.
Furthermore, any announcements regarding investments and their business performance remain relevant. However, forecasts are not guarantees. Changes in the healthcare market or regulatory adjustments can impact results.
MPH price target: What do the analysts say?
Analyst coverage of smaller investment companies is often lower than that of large corporations. According to Marketscreener Only one analyst has given a price target of 37 euros.
Price targets are based on assumptions about the performance of the investments and are subject to change at any time. A price target is not a guarantee of a specific price development.
Dividend 2026: Does this play a major role for investors?
With a dividend yield of around 5.24 percent, MPH Health Care stock is particularly attractive for income investors.
At the same time, investors should check whether the dividend is generated sustainably. With holding companies, the payout can fluctuate more, as it depends on the performance of the investments.
Should you buy MPH Health Care stock or not: What questions should you ask yourself as a beginner?
Before you decide, you can ask yourself the following questions:
- Do you understand the business model of a holding company?
- Are you aware that the value depends heavily on individual investments?
- Do you place more value on dividends or on share price growth?
- Does the stock fit your risk profile?
A clear strategy helps you to better understand fluctuations.
How does TransparentShare classify the stock?
In the TransparentShare app, the MPH Health Care share is listed as of the cut-off date of February 24, 2026. Buy recommendation classified.
The rating is based on a solid valuation, strong margins, and positive growth expectations. You can find the detailed analysis exclusively in the app.
View the full MPH Health Care review now
Outlook and Conclusion
MPH Health Care stock combines a defensive healthcare environment with an attractive dividend yield. At the same time, its performance is heavily dependent on its holdings.
For beginners, it's important to understand the business model and not just focus on the dividend yield. The TransparentShare app helps you analyze the stock in a structured and data-driven way.
Where can I find official information about MPH Health Care?
You can find official information directly on the Investor Relations page of MPH Health Care. Annual reports, general meeting information and current announcements are published there.
Which undervalued stocks are featured on TransparentShare this week?
In addition to individual analyses, TransparentShare provides a weekly overview of undervalued stocks that could be interesting from a valuation perspective.
The overview is available free of charge and helps you to discover new opportunities in a structured way.
